胰腺神经内分泌肿瘤淋巴结清扫范围应依据肿瘤位置、大小和分级确定
该回顾性研究分析了2000至2022年间接受胰腺切除术及淋巴结清扫的130例胰腺神经内分泌肿瘤患者,旨在明确哪些特征需要淋巴结清扫及清扫范围。研究发现淋巴结转移率为22.3%,肿瘤>2cm者转移率33.3%,G1和G2级分别为2.4%和31.8%,不同位置和分级肿瘤的各淋巴结站效能指数不同,结论认为清扫范围应综合考虑肿瘤大小、分级和位置。
要点
- 肿瘤>2cm、G2级或G3级者淋巴结转移风险较高,应行淋巴结清扫。
- G1级胰头肿瘤仅胰周淋巴结有清扫价值,胰体尾G1级未见转移。
- G2级胰头肿瘤需清扫胰周及肠系膜上动脉淋巴结,胰体尾需清扫胰周及脾门淋巴结。
核心结论
- 胰腺神经内分泌肿瘤的最佳淋巴结清扫范围应基于肿瘤位置、大小和分级综合确定。
研究设计与样本
- 回顾性综述了2000年至2022年间接受胰腺切除术并淋巴结清扫的患者。
- 共纳入130例患者,分析淋巴结转移频率及各站效能指数。
主要发现
- 130例中29例(22.3%)存在淋巴结转移。
- 肿瘤大于2cm者淋巴结转移率为33.3%,G1级和G2级神经内分泌肿瘤转移率分别为2.4%和31.8%。
- G1级胰头肿瘤仅胰周头淋巴结效能指数为5.0,胰体尾肿瘤无淋巴结转移。
- G2级胰头肿瘤胰周和肠系膜上动脉淋巴结效能指数分别为29.2和14.3。
- G2级胰体肿瘤胰远端淋巴结效能指数为27.3,胰尾肿瘤胰远端和脾门淋巴结效能指数分别为27.8和7.1。
临床怎么用
- 对于G1级胰体尾肿瘤可考虑省略淋巴结清扫,G1级胰头肿瘤仅需清扫胰周淋巴结。
- 对于G2级胰头肿瘤应清扫胰周及肠系膜上动脉淋巴结,胰体尾肿瘤应清扫胰远端及脾门淋巴结。
- 肿瘤大于2cm或G2/G3级者应行相应区域的淋巴结清扫。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lymph node dissection is required for many pancreatic neuroendocrine neoplasms. However, the need for such dissection has rarely been examined in detail by the tumor size, tumor location, or World Health Organization grading. The objective is to determine which characteristics of pancreatic neuroendocrine neoplasms require lymph node dissection, and to what extent lymph node dissection should be performed. METHODS: A retrospective review was performed of patients who had undergone pancreatectomy with lymph node dissection between 2000 and 2022. Frequency of lymph node metastases stratified by tumor size and grade, and efficacy index (calculated by multiplying the frequency of metastasis to the lymph node station by the 5-year overall survival rate of patients with metastasis to that station) for each lymph node station were evaluated. RESULTS: Among 130 patients, 29 (22.3%) had lymph node metastases. Tumors larger than 2 cm had a 33.3% lymph node metastasis rate, whereas grade 1 and grade 2 neuroendocrine tumors had rates of 2.4% and 31.8%, respectively. In grade 1 neuroendocrine tumor, for pancreatic head tumor, only peripancreatic head lymph node had an efficacy index of 5.0. Pancreatic body and tail tumor had no lymph node metastases. In grade 2 neuroendocrine tumor, for pancreatic head tumor, peripancreatic and superior mesenteric artery lymph nodes had efficacy indexes of 29.2 and 14.3, respectively. For pancreatic body tumor, peridistal pancreatic lymph node had an efficacy index of 27.3, whereas for pancreatic tail tumor, peridistal pancreatic lymph node and splenic hilum lymph node had an efficacy index of 27.8 and 7.1, respectively. CONCLUSION: The optimal extent of lymph node dissection for pancreatic neuroendocrine neoplasms should be determined by considering both the tumor size and grade for each tumor location.
引用
- Murase Y, Esaki M, Mizui T, et al. Optimal lymph node dissection area for pancreatic neuroendocrine neoplasms by tumor location, size, and grade. Surgery. 2024. PMID: 39740608. doi:10.1016/j.surg.2024.109029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。